TABLE 2.
Six RBPs significantly associated with the OS of BLCA patients in the training set.
| Gene symbol | ENSG ID | Coefficient | P | HR | HR (95% CI) |
| FLNA | ENSG00000196924 | −1.48536 | 0.11 | 0.23 | 0.037–1.4 |
| HSPG2 | ENSG00000142798 | 3.504967 | 0.004 | 33.28 | 3.011–367.8 |
| AHNAK | ENSG00000124942 | 1.743093 | 0.133 | 5.71 | 0.587–55.6 |
| FASTKD3 | ENSG00000124279 | −1.44735 | 0.106 | 0.24 | 0.041–1.4 |
| POU5F1 | ENSG00000204531 | −0.27992 | 0.054 | 0.76 | 0.569–1.0 |
| PCSK9 | ENSG00000169174 | 0.346457 | 0.013 | 1.41 | 1.074–1.9 |
BLCA, Bladder cancer; OS, Overall survival; HR, Hazard ratio; 95% CI, 95% Confidence interval. Bold values are significant to p < 0.05.